titrated

Related by string. titrating * * titrated glipizide plus . titrated glipizide . dose titrated *

Related by context. All words. (Click for frequent words.) 64 titrate 64 administered subcutaneously 63 mcg kg 63 mg d 63 dose titration 62 LANTUS R 62 serum phosphorus 61 titrating 61 dosing interval 61 mg QD 61 IV bolus 60 #mg/m# [002] 60 lispro 60 intermittent dosing 60 insulin detemir 60 nicardipine 60 titration 59 oral prednisone 59 mg orally 59 mealtime insulin 59 OADs 59 μg kg 59 4mg/kg 59 mg m 59 mcg BID 59 mg/m2 58 mg subcutaneously 58 HbA1c levels 58 mg/# hr 58 dosed 58 BROVANA 58 #mg/day [001] 58 undetectable HCV RNA 58 #mg/day [002] 58 biphasic insulin aspart 58 detemir 58 bronchodilation 58 APTIVUS r 58 salmeterol fluticasone 58 NovoLog ® Mix 58 mg dosed 58 BENICAR 58 subcutaneous injections 57 PREZISTA r 57 urate lowering therapy 57 LATUDA 57 mcg 57 #mg/m# [001] 57 mcg mL 57 mL kg 57 mg dose 57 #mg dose [002] 57 intravenous morphine 57 CIMZIA TM 57 plasma uric acid 57 #mg/kg [002] 57 Lantus R 57 mg TID 57 nebulization 57 ascending dose 57 BYSTOLIC 57 serum potassium 56 Dosing 56 abacavir lamivudine 56 plasma concentrations 56 dosing 56 atazanavir ritonavir 56 mg/# hours 56 mg/m2/day 56 3mg 56 oral antidiabetic medication 56 LEXIVA r 56 μg 56 q#h 56 creatinine clearance 56 #mg doses [002] 56 spontaneous bowel movements 56 GnRH agonist 56 ropivacaine 56 ug kg 56 remifentanil 56 certolizumab pegol 56 q8h 56 plasma glucose levels 56 subcutaneous enoxaparin 56 dosage regimen 56 8mg/kg 56 serum phosphorous 56 anticoagulated 56 mg BID 56 mg kg 56 mcg QD 56 plasma glucose 56 mm Hg 56 mCi kg 56 AGILECT R 56 subcutaneous infusion 56 kg -1 56 mg 55 ritonavir boosted 55 rapid virologic response 55 HBeAg seroconversion 55 8mg 55 unfractionated heparin 55 systemic hypotension 55 administered orally 55 timepoint 55 Dose escalation 55 NPH insulin 55 esomeprazole 55 intradermal injections 55 corticosteroid dose 55 mg kg dose 55 hours postdose 55 ALVESCO 55 #mg dose [003] 55 #mg QD [001] 55 active comparator 55 peak plasma concentrations 55 FEV1 55 H2RAs 55 2mg 55 sinus rhythm 55 dose colchicine 55 #.#mg/dL 55 mg eq 55 piperacillin tazobactam 55 intravenous infusion 55 microgram kg 55 #mg BID [001] 55 administered intravenously 55 injected intravenously 55 #mg BID [003] 55 desvenlafaxine succinate 55 CrCl 55 BENICAR HCT 55 quetiapine 55 dose escalation 55 fasting plasma glucose 55 bolus dose 55 controlled analgesia PCA 54 fasting plasma glucose FPG 54 tapentadol ER 54 hemoglobin A1c HbA1c 54 QTcF 54 lopinavir ritonavir 54 Q2W 54 intravenous bolus 54 QD dosing 54 dosage regimens 54 dobutamine 54 dosing cohort 54 certolizumab 54 ARIKACE 54 mcg kg min 54 mEq L 54 otamixaban 54 INVEGA ® 54 #mmHg [001] 54 continuous intravenous infusion 54 mg dL 54 severe renal impairment 54 serum urate 54 hour bronchodilation 54 KOMBIGLYZE XR 54 tolterodine ER 54 fluticasone propionate 54 postoperatively 54 dosed orally 54 divalproex sodium 54 μmol L 54 visilizumab 54 MULTAQ 54 Index CDAI 54 intramuscularly 54 oral rivaroxaban 54 5mg/kg 54 mg qd 54 adalimumab 54 daily subcutaneous injections 54 insulin glulisine 54 serum sodium 54 Perforomist TM Inhalation Solution 54 solifenacin 54 ribavirin RBV 54 #mg dosing 54 racemic albuterol 54 LPV r 54 antihypertensive medications 54 LAB GHRH 54 diuretic chlorthalidone 54 bolus injection 54 VAPRISOL 54 peginterferon alfa 2a 54 irbesartan 54 xanthine oxidase inhibitor 54 aripiprazole 54 6mg 54 bupivacaine 54 lanthanum carbonate 54 lopinavir r 54 trough FEV1 54 budesonide pMDI 54 saline placebo 53 mg/m2 dose 53 aplindore 53 dosing cohorts 53 hemoglobin A1c levels 53 Pharmacokinetic parameters 53 pharmacokinetic parameters 53 epoetin alpha 53 pentoxifylline 53 ml kg 53 Crohn Disease Activity 53 lumbar spine BMD 53 peginterferon alfa 2b 53 Cmax 53 PROMACTA 53 Peg IFN 53 PRADAXA 53 mcg ml 53 oral antidiabetes 53 mmHg 53 mL/min/#.# m 2 53 mmol l 53 aspartate aminotransferase AST 53 timepoints 53 injected subcutaneously 53 insulin degludec 53 MADRS score 53 inhalations twice 53 β blocker 53 rt PA 53 LCP Tacro ™ 53 NATRECOR R 53 subcutaneous SC 53 #mg [003] 53 Montgomery Asberg Depression 53 #mg #mg [001] 53 COZAAR 53 inotropic agents 53 weekly intravenous infusions 53 monotherapy 53 serum potassium levels 53 primary hypercholesterolemia 53 ibandronate 53 hyperphenylalaninemia HPA due 53 oral prednisolone 53 EMEND 53 #mg QD [002] 53 glycosylated hemoglobin HbA1c 53 hypomagnesemia 53 serum phosphate 53 flutamide 53 NIASPAN 53 mg/# mg [002] 53 mesalamine granules 53 placebo intravenously 53 monoamine oxidase inhibitors MAOIs 53 maximal tolerated 53 achieved statistical significance 53 μg dose 53 amlodipine 53 mg dl 53 vasodilators 53 infliximab 53 sitagliptin 53 Lamictal XR 53 Omacetaxine mepesuccinate 53 eszopiclone 53 ziprasidone 53 subcutaneous insulin 53 Apidra R 53 9mg 53 quinidine 53 oxycodone CR 53 amprenavir 53 APIDRA R 53 colesevelam HCl 52 OMS# 52 candesartan cilexetil 52 mg m² 52 subcutaneous injection 52 subcutaneously administered 52 subcutaneously 52 nmol liter 52 XOPENEX HFA 52 dose cohorts 52 HbA 1c 52 flecainide 52 HCTZ 52 acute gout flares 52 AUC0 52 analgesic efficacy 52 vecuronium 52 clevidipine 52 basal insulin 52 intravenously administered 52 postprocedure 52 mg/m2 administered 52 intramuscular injections 52 Index CDAI score 52 systemic corticosteroid 52 administered intramuscularly 52 β blockers 52 hypokalemia 52 iPTH 52 antiretroviral naive 52 nelfinavir 52 flumazenil 52 R entecavir 52 placebo 52 intravitreal injection 52 zonisamide SR 52 gout flares 52 weekly subcutaneous injections 52 mometasone furoate 52 OGTT 52 #mg/#mg 52 tenofovir emtricitabine 52 LEXIVA 52 postdose 52 sUA 52 opioid analgesia 52 randomized #:# 52 Thrombolysis 52 vasopressor 52 glargine 52 fasting blood glucose 52 infused intravenously 52 NUCYNTA R 52 lesinurad 52 glulisine 52 fluticasone furoate 52 copies mL 52 dose escalation phase 52 ABILIFY 52 systolic BP 52 pyrimidine nucleoside analog 52 dose cohort 52 AZOR 52 alpha blocker 52 APTIVUS 52 ascending doses 52 KAPIDEX 52 rFSH 52 primidone 52 PASI scores 52 EMSAM 52 #.#mg/kg [002] 52 deferoxamine 52 ribavirin USP 52 NUCYNTA ® 52 potent CYP#A# inhibitors 52 rotigotine 52 aminotransferase levels 52 lowering blood glucose 52 PEGINTRON 52 μg mL 52 antihypertensive therapy 52 Inventory BPI 52 steroid dexamethasone 52 oral methylnaltrexone 52 tolerated dose MTD 52 triamcinolone 52 ACR# response 52 #.#/#.# mmHg [001] 52 prospectively stratified 52 tolvaptan 52 ABILIFY Injection 52 alteplase 52 ALA PDT 52 corticosteroid therapy 52 ULTRAM ER 52 RSD# 52 aminotransferases 52 plus ribavirin 52 statin monotherapy 52 Elitek 52 oxcarbazepine 52 serum cortisol 52 overt nephropathy 52 3mg/kg 52 oral corticosteroids 52 Inhalation Aerosol 52 International Normalized Ratio 52 Oral corticosteroids 52 PegIFN RBV 52 fluticasone 52 SCIg 52 DAPT 52 pegnivacogin 52 cinacalcet 52 metformin sulphonylurea 52 Apidra ® 52 Rating Scale MADRS 52 inhaled corticosteroids ICS 51 fosamprenavir 51 serum concentrations 51 subcutaneous dose 51 guanfacine 51 Victoza R 51 ACTOplus met XR 51 Monotherapy 51 mg simvastatin 51 citalopram 51 serum uric acid 51 administered intranasally 51 dose regimens 51 glatiramer acetate 51 coadministered 51 epoetin alfa 51 extubated 51 INVEGA ™ 51 serum glucose 51 rhEPO 51 RLAI 51 ACTEMRA TM 51 dexmedetomidine 51 rizatriptan 51 ml min 51 trandolapril 51 ritonavir boosted protease inhibitor 51 label dose titration 51 mcg Albuferon 51 serum testosterone 51 dopamine partial agonist 51 FOSRENOL R 51 pg mL 51 oral levofloxacin 51 #.#g/day 51 atorvastatin #mg 51 BoNTA 51 ARB telmisartan 51 octreotide LAR 51 mm Hg systolic 51 mg RDEA# 51 laxation 51 tizanidine 51 g dL 51 inhaled corticosteroid 51 AZILECT 51 LMWH 51 moderate renal impairment 51 mg kg hr 51 inhaled iloprost 51 #mmHg [002] 51 treprostinil 51 neurologic progression 51 ng ml 51 intra articular injection 51 NATRECOR ® 51 TRIZIVIR 51 mitoxantrone 51 COPEGUS 51 dapagliflozin plus 51 formoterol fumarate 51 postop 51 subcutaneously injected 51 fluorouracil 51 ng mL 51 Traficet EN 51 voriconazole 51 undetectable viral 51 kilogram mg kg 51 PRADAXA #mg 51 VIRAMUNE 51 pyridostigmine 51 ATACAND 51 IIIa inhibitors 51 NovoMix ® 51 MIRAPEX 51 detectable HCV RNA 51 placebo p 51 min -1 51 glycoprotein IIb IIIa inhibitors 51 hypomagnesemia hypocalcemia 51 EUFLEXXA R 51 tirofiban 51 CDAI 51 SUSTENNA TM 51 granisetron 51 zolmitriptan 51 Mg Uk 51 tinzaparin 51 FFNS 51 fluticasone salmeterol 51 triptorelin 51 interferon alfa 2b 51 glycated hemoglobin levels 51 systemic corticosteroids 51 mL 51 ONGLYZA 51 antihypertensive agents 51 systolic diastolic blood 51 Primary endpoints 51 clomipramine 51 Acetate Rectal Suppositories 51 mCi m 2 51 pyrazinamide 51 dose proportional pharmacokinetics 51 hematological parameters 51 eptifibatide 51 CRESTOR rosuvastatin calcium 51 Hb A1C 51 insulin lispro 51 glimepiride 51 FOLFOX6 51 titrated glipizide 51 tipranavir r 51 IELT 51 4mg 51 zoledronate 51 forodesine 51 PEGylated anti 51 lopinavir ritonavir plus 51 glycemia 51 mg hydrochlorothiazide 51 Arikace 51 PROCRIT 51 oral corticosteroid 51 ropinirole 51 A1C levels 51 Sitagliptin 51 antidepressant therapy 51 mg/m2 IV 51 dosing frequency 51 Ramipril 51 elevated creatinine 51 non splenectomized 51 bronchodilator 51 mg administered orally 51 tranylcypromine 51 unfractionated heparin UFH 51 Acute Ischemic Stroke 51 postmenopausal osteoporotic women 51 TDF FTC 51 Sumatriptan OS 51 mg iv peramivir 51 ng dL 51 AVELOX 51 pressurized metered dose 50 euvolemic 50 avosentan 50 intravesical 50 cholestyramine 50 5mg 50 MAOI 50 hypogonadal men 50 JANUMET 50 clodronate 50 bezafibrate 50 Paliperidone 50 metformin sulfonylureas 50 sirolimus 50 intravenous IV infusion 50 electrical cardioversion 50 antiarrhythmic drug 50 montelukast 50 efavirenz EFV 50 mg kg IV 50 fondaparinux 50 Perforomist Inhalation Solution 50 creatinine ratio 50 mg ritonavir 50 metformin sulfonylurea 50 #/#mg 50 intravenous doses 50 #mg tablet [002] 50 Pegasys ® 50 citalopram hydrobromide 50 subconjunctival injection 50 peg IFN 50 serum phosphorus levels 50 Visual Analogue Scale VAS 50 transdermal fentanyl 50 Pegasys plus Copegus 50 dosing intervals 50 Hb levels 50 postintervention 50 #μg [001] 50 mcg albinterferon alfa 2b 50 rocuronium 50 mg q8h 50 coadministration 50 dopamine receptor agonist 50 budesonide formoterol 50 telaprevir dosing 50 A1c levels 50 APTIVUS ritonavir 50 cis retinoic acid 50 Single Dose 50 Tiotropium 50 serum phosphate levels 50 FOLPI regimen 50 mcg dose 50 MoxDuo TM IR 50 refractory NSCLC 50 PRISTIQ 50 neostigmine 50 amphotericin B 50 randomized 50 IU mL 50 randomized #:#:# 50 Zileuton 50 nab paclitaxel 50 hemoglobin concentration 50 HCV RESPOND 2 50 IOP lowering 50 Locteron administered 50 p = NS 50 systemic immunosuppressive 50 Vagifem 50 loxapine 50 sufentanil 50 Psoriasis Area 50 HbA1c 50 idarubicin 50 evaluable subjects 50 divalproex 50 lorazepam Ativan 50 test OGTT 50 stavudine 50 deferasirox 50 injectable emulsion 50 intravenous tissue plasminogen 50 potassium sparing diuretics 50 EXJADE 50 EFFEXOR XR 50 edoxaban 50 Extended Release 50 mg FV 50 SVR# 50 dalteparin 50 RECIST criteria 50 darbepoetin alfa 50 1mg/kg 50 pharmacodynamic effects 50 rHuPH# 50 venlafaxine ER 50 infliximab monotherapy 50 alanine aminotransferase ALT 50 tiotropium 50 mmHg systolic 50 RGT arm 50 urinary sodium excretion 50 glycated hemoglobin HbA1c 50 anticoagulant medications 50 ng dl 50 primary efficacy endpoint 50 1mg 2mg 50 double blinded placebo 50 ASMANEX 50 rapid virological response 50 secondary efficacy endpoint 50 IFN alfa 50 concentration Cmax 50 MAO inhibitor 50 Vincristine 50 maximal dose 50 GAMMAGARD 50 leukocyte count 50 virological response 50 lopinavir r arm 50 aspartate aminotransferase 50 insulin glargine 50 paricalcitol 50 comparator arm 50 binary restenosis 50 Exenatide 50 allopurinol 50 beta2 agonist 50 #mg ATC 50 acarbose 50 nevirapine Viramune 50 monoamine oxidase inhibitors 50 lactulose 50 aspirin heparin 50 dexamethasone Decadron 50 insulin aspart 50 Zoledronic acid 50 angiotensin converting enzyme inhibitor 50 PEG IFN 50 Fasting plasma glucose 50 Valcyte tablets 50 Tasigna prolongs 50 abacavir Ziagen 50 ULORIC 50 ganciclovir 50 NovoRapid 50 NEXIUM 50 unblinded 50 Benazepril 50 Lantus ® 50 aPTT 50 elagolix 50 ipsilateral stroke 50 CIMZIA R 50 CIMZIA TM certolizumab pegol 50 5mg dose 50 1mg 50 sequestered naltrexone 50 Solid Tumors criteria 50 Raptiva r 50 mcg doses 50 mg kg intravenously 50 milrinone 50 #mg #mg #mg [003] 50 lacosamide 50 Ambulatory Blood Pressure 50 MIRCERA 50 nasal lavage 50 SPRYCEL 50 clinically meaningful reductions 50 Quetiapine 50 GLP1 agonist 50 PREZISTA ritonavir 50 ZP PTH 50 tacrolimus 50 bisoprolol 49 HMG CoA reductase inhibitor 49 beclomethasone dipropionate 49 ARCOXIA 49 maximally tolerated dose 49 glomerular filtration 49 darunavir ritonavir 49 histrelin 49 incontinence episodes 49 FOSRENOL ® 49 AZILECT R 49 #/#.# mcg 49 DULERA 49 PREMARIN Vaginal Cream 49 Cardiopulmonary bypass 49 periprocedural 49 #mg doses [001] 49 virologic failure 49 MENOPUR 49 dexamethasone 49 urinary albumin excretion 49 antiandrogen 49 PEGINTRON TM 49 maximal doses 49 NSTE ACS 49 mg ustekinumab 49 Dosed 49 PEG Intron ® 49 olanzapine 49 postoperative 49 CK # administered 49 Percutaneous Coronary Intervention 49 plus methotrexate 49 T2DM 49 sulfonylurea 49 Orally administered 49 adefovir 49 aminotransferase elevations greater 49 statistically significant reduction 49 hemoglobin Hb 49 lavage 49 HBV DNA levels 49 tamsulosin 49 orally inhaled 49 adjunctive placebo 49 pretreatment baseline 49 Mg Usa 49 mild renal insufficiency 49 HbA 1c levels 49 milliliters mL 49 periodically reassessed 49 HF ACTION 49 venlafaxine XR 49 biochemical relapse 49 dose Qnexa 49 Capesaris 49 #mg dose [001] 49 NOXAFIL Oral Suspension 49 bolus doses 49 mesalamine 49 Phase 2b study 49 anticoagulation therapy 49 Intrathecal 49 brand ciclesonide HFA 49 peginterferon 49 pioglitazone 49 plasma HCV RNA 49 subcutaneous doses 49 Decadron 49 calcipotriene 49 CIMZIA ™ 49 Neupro R 49 EMBEDA TM 49 concomitant medications 49 nitroprusside 49 weekly subcutaneous injection 49 mg Pycnogenol 49 REBETOL 49 urinary N telopeptide 49 achieved ACR# 49 serum HBV DNA 49 escitalopram oxalate 49 ketorolac 49 #μg [002] 49 QTc 49 INVEGA ® SUSTENNA ® 49 salmeterol inhalation powder 49 anticlotting drugs 49 symptomatic hypotension 49 Scale EDSS 49 Free Survival PFS 49 lanreotide 49 UA NSTEMI 49 ALT normalization 49 SYMBICORT 49 anticoagulation 49 lipid lowering therapy 49 anticholinergic agents 49 mEq 49 hydrochloride tablets 49 REYATAZ r 49 milligrams mg 49 PREMPRO 49 fraction LVEF 49 mg dosed once 49 serum calcium 49 #.#/#.# mm Hg [003] 49 leukopenia pancytopenia thrombocytopenia 49 narrow angle glaucoma 49 undergoing coronary angiography 49 dihydroergotamine 49 Indacaterol 49 treatment naive genotype 49 quetiapine XR 49 progression TTP 49 oral antidiabetes drugs 49 pioglitazone HCl 49 hepatic function 49 achieved PASI 49 alanine aminotransferase 49 extubation 49 procalcitonin 49 naltrexone hydrochloride 49 budesonide 49 peripherally acting 49 degarelix 49 ZYVOX 49 inhibit platelet function 49 hMG 49 intranasal steroid 49 prespecified 49 BUPHENYL R sodium phenylbutyrate 49 cGy 49 Diovan HCT 49 g dl 49 sulfonylurea metformin 49 baclofen 49 thrombin inhibiting aptamer 49 placebo p = 49 spironolactone 49 sUA levels 49 mg doses 49 monoamine oxidase inhibitor MAOI 49 mg subcutaneous 49 plasma pharmacokinetics 49 Creatinine 49 Nasacort AQ 49 nimodipine 49 HAART regimens 49 #mg ritonavir 49 JANUVIA 49 mitomycin C 49 FIRMAGON 49 -#.# mg dL [002] 49 DEXILANT 49 Butrans 49 lispro alone 49 normotensive 49 ISTODAX 49 sustained virological response 49 Hydrochloride 49 n = 49 R# #mg BID 49 x ULN 49 metered dose 49 tacrolimus ointment 49 oral ribavirin 49 primary axillary hyperhidrosis 49 cefuroxime 49 ejection fractions 49 microalbuminuria 49 Posaconazole 49 nebulized 49 captopril 49 blood glucose concentrations 49 generation purine nucleoside 49 octreotide 49 hsCRP levels 49 administered concomitantly 49 Chemophase 49 preoperatively 49 Serum potassium 49 Catapres 49 mm Hg diastolic 49 ACE inhibitor perindopril 49 undetectable viral load 49 aspirin clopidogrel 49 GSK# [001] 49 doxazosin 49 corrected QT interval 49 Orally Disintegrating Tablets 49 Ondansetron Injection USP 49 mL min 49 Anturol TM 49 Aclidinium 49 loperamide 49 DU #b 49 intravenous dose 49 lamotrigine 49 Levemir ® 49 nmol 49 nadolol 49 TAXOTERE R 49 fibrinolytic 49 Peginterferon Alfa 2a 49 baseline HbA1c 49 HIV RNA 49 oxymorphone IR 49 IIIa inhibitor 49 INFERGEN 49 azilsartan medoxomil 49 mmol L 49 umol L 49 serum PTH 49 urate lowering 49 mU liter 49 Abrupt discontinuation 49 albiglutide 49 selegiline 49 evaluable 49 topical calcineurin inhibitors 49 Lanoxin 49 serum magnesium 49 hydrochlorothiazide tablets 49 blood phenylalanine Phe 49 valsartan amlodipine 49 rFVIIa 49 mmHg diastolic 49 posttransplant 49 HCV SPRINT 49 system REG1 consists 49 anticholinergics 49 mu g 49 FEV1 forced expiratory 49 isotonic saline 48 venlafaxine 48 Phase 2a trial 48 tenecteplase 48 MAS XR 48 relapsed MM 48 aripiprazole Abilify 48 emtricitabine tenofovir 48 bosentan 48 teriflunomide 48 dosing regimens 48 endoscopic remission 48 UPDRS scores 48 Negative Syndrome 48 ritonavir boosted atazanavir 48 blood counts CBCs 48 clotrimazole 48 CorVue ™ 48 APRISO 48 inadequate glycemic 48 PREZISTA rtv 48 interquartile range 48 evaluable patients 48 acetazolamide 48 leukotriene receptor antagonist 48 statistically significant p = 48 Prograf ® 48 warfarin sodium 48 idraparinux 48 Peginterferon 48 Digoxin 48 Fluticasone 48 Methylnaltrexone 48 lipid lowering agents 48 peg interferon 48 rilpivirine 48 retinal thickness 48 INTEGRILIN R 48 risperidone Risperdal 48 d4T 48 amlodipine beta blockers 48 nasal symptom 48 ventilatory 48 paliperidone palmitate 48 mg subcutaneous injection 48 alfentanil

Back to home page